Therefore, following the hypothesis that GDF15 and FGF21 levels could be related to the improvements of obesity‐related conditions and the resolution of T2D after bariatric surgery, this study aimed to assess the impact of RYGB on their circulating levels as well as their possible relation to weight and fat loss. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.